KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 8,720.00
+1,220.00 (16.27%)
At close: Oct 2, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 95.11 billion as of October 2, 2026. Its market cap has decreased by -37.36% in one year.
Market Cap
95.11B
Enterprise Value
100.66B
Revenue
93.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,720.00
ChartMarket Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 95.11B, a decrease of -48.25%. That is a compound annual growth rate of -10.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 95.11B | -32.92% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 95.70B |
| DongKoo Bio & Pharma | 95.05B |
| H.PIO | 88.37B |
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 82.40B |
| Pharos iBio | 79.49B |
| Daehan Nupharm | 77.62B |
| Sinil Pharmaceutical | 73.72B |